You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 39 No. 2, February 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Naloxone on the 'On-Off' Syndrome in Patients Receiving Long-term Levodopa Therapy

Marco Trabucchi, MD; Sirio Bassi, MD; Lodovico Frattola, MD

Arch Neurol. 1982;39(2):120-121.


Abstract

• Naloxone hydrochloride, an opiate antagonist, was given to six parkinsonian patients suffering from the "on-off" phenomenon. Although the drug does not modify the cardinal symptoms of parkinsonism, it reduces dyskinetic movements and the length of the rigid phase. There may be an interaction of opiate receptors with the different neurotransmitter systems involved in the on-off syndrome.



Author Affiliations

From the Departments of Pharmacology (Dr Trabucchi) and Neurology (Drs Bassi and Frattola), University of Milan (Italy).


Footnotes

Accepted for publication March 24, 1981.

Reprint requests to Ospedale Bassini, Via Gorki 50, 20092, Cinisello Balsamo, Italy (Dr Frattola).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow et al.
Neurology 2009;72:S1-S136.
ABSTRACT | FULL TEXT  

New Therapeutic Approaches to Parkinson's Disease Including Neural Transplants
Kuan and Barker
Neurorehabil Neural Repair 2005;19:155-181.
ABSTRACT  

Cardiac Cephalgia is Not Necessarily an Exertional Headache: Case Report
Gutierrez-Morlote and Pascual
Cephalalgia 2002;22:765-766.
FULL TEXT  

Presynaptic modulation of synaptic transmission by opioid receptor in rat subthalamic nucleus in vitro
Shen and Johnson
J. Physiol. 2002;541:219-230.
ABSTRACT | FULL TEXT  

Endomorphin-1: Induction of Motor Behavior and Lack of Receptor Desensitization
Mehta et al.
J. Neurosci. 2001;21:4436-4442.
ABSTRACT | FULL TEXT  

An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Olanow et al.
Neurology 2001;56:S1-S88.
FULL TEXT  

High dose naltrexone for dyskinesias induced by levodopa
Manson et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:554-556.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.